PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2017

PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

(1) , (2) , (3) , (4, 5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17, 18) , (10)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Dates et versions

hal-01632415 , version 1 (10-11-2017)

Identifiants

Citer

J-B. Bachet, O. Lucidarme, C.B. Levache, E. Maillard, J.L. Raoul, et al.. PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial. the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. pp.505P, ⟨10.1093/annonc/mdx393.031⟩. ⟨hal-01632415⟩
47 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More